Why Product Selection Matters for Pharma Distributors
In India's competitive pharmaceutical distribution landscape, choosing the right products can make or break your business. With over 60,000 registered pharmaceutical companies and a market valued at $50 billion, identifying fast-moving products is critical for maximising ROI and minimising dead stock.
At Medrizehealthcare, we analyse enquiry data across thousands of B2B transactions daily. Based on our 2025 data, here are the top 10 product categories every distributor should stock.
1. Antibiotics (Amoxicillin, Azithromycin, Cefixime)
Antibiotics remain the backbone of pharma distribution. Amoxicillin+Clavulanate combinations and third-generation cephalosporins like Cefixime are seeing 18% year-on-year growth in B2B enquiries.
- Best sellers: Amoxicillin 500mg, Azithromycin 500mg, Cefixime 200mg
- Margin: 15–22% for distributors
- Min order: 5,000 strips typically
2. Antidiabetic Medicines (Metformin, Glimepiride)
India has 101 million diabetic patients — the world's second-largest diabetic population. Metformin SR 500mg and Glimepiride+Metformin combinations are consistently among the top enquired products on Medrizehealthcare.
3. Cardiovascular Drugs (Atorvastatin, Amlodipine, Telmisartan)
With cardiovascular disease accounting for 28% of all deaths in India, this segment offers stable, repeat-order business. Atorvastatin 10mg and Telmisartan 40mg are high-demand molecules.
4. Proton Pump Inhibitors (Pantoprazole, Omeprazole)
Gastric medicines have universal demand. Pantoprazole 40mg is one of the most prescribed molecules in India with excellent distributor margins of 20–28%.
5. Vitamins & Nutritional Supplements
Post-COVID, immunity boosters and multivitamins have seen a permanent demand uplift. Vitamin D3, B-Complex, and Zinc supplements are fast-moving across all retail channels.
6. Dermatology Products (Creams & Ointments)
Antifungal creams (Clotrimazole, Ketoconazole) and corticosteroid combinations have high OTC demand. This segment has low return rates and stable pricing.
7. Pain Management (Diclofenac, Aceclofenac, Paracetamol)
NSAIDs and analgesics are evergreen. Aceclofenac+Paracetamol combinations are particularly fast-moving in semi-urban and rural markets.
8. Respiratory Medicines (Salbutamol, Montelukast, Levosalbutamol)
With rising air pollution levels, respiratory medicines have seen a 23% demand increase. Montelukast+Levocetirizine combinations are top sellers for paediatric and adult segments.
9. Nutraceuticals (Omega-3, Probiotics, Calcium)
The Indian nutraceutical market is growing at 21% CAGR. Calcium+Vitamin D3 combinations and Omega-3 softgels offer excellent margins of 30–40% for distributors.
10. Gynaecology Products (Folic Acid, Iron+Folic, Progesterone)
Iron+Folic Acid combinations are mandated in government health programmes, ensuring steady institutional demand. Private market demand is equally strong.
How to Source These Products on Medrizehealthcare
Finding verified suppliers for these fast-moving products is simple on Medrizehealthcare. Browse by category, compare multiple verified manufacturers, and post your bulk enquiry directly — no middlemen, no hidden fees.
Ready to stock up? Post your bulk enquiry today and get competitive quotes from verified Indian manufacturers within 24 hours.